$IGXT financials after close
OTC $0.60
Record 2015
$IGXT financials after close
OTC $0.60
Record 2015 Financial Results
an increase of 82% over the same period last year
Website
Shares Outstanding: 63.62M
Float: 53.15M
% Held by Insiders: N/A
Headlines
IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. Its product portfolio comprises INT0001/2004 for coronary heart failure and hypertension; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2007 for the treatment of migraine; INT0010/2006 for cancer pain; INT0024/2010 for idiopathic pulmonary fibrosis; INT0027/2011 for opioid dependence; INT0030/2011 for animal health; and INT0036/2012 for central nervous system disorders, as well as INT0037/2013, INT0039/2013, and INT0040/2013. The company develops its products based on three delivery platform technologies, which consist of the Multilayer Tablet technology that allows for the development of oral controlled-release products; the Oral Film technology, which allows for the delivery of pharmaceuticals to the oral cavity; and the Mucoadhesive Tablet technology for the controlled release of active substances to the oral mucosa. It also provides product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The company has a strategic alliance with LTS Lohmann Therapie-Systeme AG to manufacture pharmaceutical products using VersaFilm drug delivery technology; and a strategic manufacturing partnership with Pillar5 Pharma Inc. It also has a co-development and commercialization agreement with RedHill Biopharma Ltd. for the co-development and commercialization of INT0008/2007. IntelGenx Technologies Corp. was founded in 2003 and is based in Ville Saint Laurent, Canada .
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...
Continue Reading
Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...
Continue Reading
California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...
Continue Reading
A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...
Continue Reading
AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...
Continue Reading
Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...
Continue Reading
Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...
Continue Reading
Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...
Continue Reading
LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...
Continue Reading
Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...
Continue Reading
Top 5 Most Recently Viewed Articles
DuckChain and AWS Unite for a Groundbreaking Hackathon In an exciting collaboration between DuckChain and Amazon Web Services (AWS), the Hack: AI Unchained event has launched! This global hackathon aims to unite AI developers, Web3 builders, and innovators passionate about decentralized infrastructure. Set to run for a week, this event is among the most significant AI and...
Continue Reading
Tradewinds Universal Initiates Financial Evaluation Tradewinds Universal, Inc. (NASDAQ: TRWD) has embarked on a significant financial review of Peppermint Hippo as part of its strategic expansion into the adult hospitality sector. This initiative is a proactive step towards solidifying its presence amidst the evolving dynamics of the adult entertainment industry....
Continue Reading
Overview of the Dairy Products Market Growth The global dairy products market has been making significant strides, recently valued at US$ 525.5 billion in the previous year. Projections indicate a substantial increase, with expectations to hit US$ 693.4 billion by 2033, reflecting a compound annual growth rate (CAGR) of 3.13% during the forecast period. Factors Driving...
Continue Reading
Taiwan Semiconductor Manufacturing Company (NYSE: TSM), or TSMC, threw down the gauntlet in 2024 by holding a commanding 62% of the global foundry market share. When you look at competitors like Samsung, which scrapes by with just 13%, it’s clear TSMC's got a stranglehold on chip production. They’re not just sitting pretty either; they were ramping up their capital...
Continue Reading
Why Deep Cleaning Matters Dentists have been jawing about oral hygiene for decades, but when Dr. John Morgan Jackson III, D.M.D., speaks up about deep cleaning, it's worth paying attention. HelloNation's latest dive into this topic sheds light on why deep cleaning goes beyond the usual, mundane scrape and polish of regular cleanings. For those sitting in the dental chair,...
Continue Reading